Clinical Trial Update: Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing neoadjuvant abiraterone plus LHRH therapy to LHRH alone in prostate cancer has completed and posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprolide acetate (Leuprolide acetate)
• Zytiga (abiraterone acetate)

Snippet

Sponsor: Cougar Biotechnology, Inc. | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-04-09